Marked CD10 expression in the NEC component was associated with a retained expression of PTEN and a decreased expression of phosphorylated Akt, which may have resulted in anti-cancer effects and contributed to the favorable prognosis. The gene discussed is PTEN; the disease is neuroendocrine carcinoma.